Back

Novel and emerging markers of thrombosis in COVID-19

17 March 2022 (00:00 - 00:00)
Organised by: Logo
Seminar Presentation Part of: Session 2: COVID-19 and thrombotic complications Thrombosis, Bleeding Open Access Hot topics and new insights for Thrombosis 2022 WG on Thrombosis

About the speaker

Photo
Professor Diana A Gorog

National Heart and Lung Institute Imperial College, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Soluble Biomarkers of Thrombosis in COVID-19.
Associate Professor B. Gigante (Stockholm, SE)
Video
Presentation thumbnail
Thrombotic complications and the vaccine-induced thrombocytopenia of Covid19 vaccines.
Doctor P. Holme (Osla, NO)
Video
Presentation thumbnail
Q&A.

Access the full session

Session thumbnail
Session 2: COVID-19 and thrombotic complications
Video

The Event

Event poster

Hot topics and new insights for Thrombosis 2022

17 March 2022 00:00 CET
You may be interested in
thumbnail
Congress Presentation
Endothelial biomarkers (Von Willebrand Factor, BDCA3, Urokinase) as predictors of mortality in COVID-19 patients.
22 May 2023
thumbnail
Congress Presentation
Inflammatory thrombosis is a denominator of permanent platelet activation in chronic thromboembolic pulmonary hypertension
1 September 2025
thumbnail
Congress Presentation
Thromboembolic events in the follow up of COVID-19 patients
29 June 2021
thumbnail
Congress Presentation
Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources